Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago. These ...

While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Cross Country Healthcare is being acquired by P/E firm Knox Lane for $13.25 per share in an all-cash transaction. Knox Lane has a healthcare staffing business in its portfolio, but the merger involves ...

Cross Country Healthcare is back in focus after analysts reset price targets into the US$10 to US$14 range, while modelled ...

Cross Country Healthcare (CCRN) closed the most recent trading day at $23.55, moving -1.63% from the previous trading session. This change lagged the S&P 500's daily gain of 0.92%. At the same time, ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cross ...

Cross Country Healthcare and Florida Atlantic University’s Christine E. Lynn College of Nursing released Purpose Under ...

US Stocks Likely To Open Higher After Nasdaq 100 Enters Correction Zone: 'Economic Resilience Provides A Foundation For Market Stabilization,' Says Expert U.S. stock futures rose on Friday following ...

Fintel reports that on May 8, 2026, Benchmark downgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Buy to Hold. Analyst Price Forecast Suggests 9.57% Downside As of April 28, ...